The reduction of alpha diversity within the patients with GDM is in line with the remarkable hormonal, immunological, and metabolic changes taking place during the third trimester to promote maternal weight gain, increasing circulating pro-inflammatory cytokines, and insulin resistance, which are accentuated in the presence of gestational hyperglycemia29. This evidence concerns the gene INS and gestational diabetes.